SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Balaxi Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532597

INE618N01022

24.0912014

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALAXI

24.57

126.15

EPS(TTM)

Face Value()

Div & Yield %

0.93

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	60.99	70.20	108.14	101.29	86.87	45.63
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	60.99	70.20	108.14	101.29	86.87	45.63
Other Income	5.37	2.40	6.60	2.75	1.81	0.59
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	66.36	72.60	114.74	104.04	88.68	46.22
EXPENDITURE :
Raw Materials	50.94	56.49	82.10	76.92	63.33	32.83
Power & Fuel Cost	0.04	0.04	0.04	0.02	0.00	0.00
Employee Cost	4.87	5.04	4.04	2.90	1.95	1.75
Other Manufacturing Expenses	0.24	0.21	0.25	0.13	0.12	0.00
Selling & Administrative Expenses	1.97	2.58	4.51	3.79	2.06	1.71
Miscellaneous Expenses	0.32	0.49	0.33	0.23	0.39	0.69
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	58.38	64.84	91.27	83.99	67.85	36.99
Operating Profit	7.98	7.75	23.48	20.05	20.83	9.24
Interest	2.24	1.66	0.51	0.10	0.15	0.05
Gross Profit	5.74	6.09	22.97	19.95	20.68	9.19
Depreciation	0.46	0.51	0.52	0.25	0.09	0.01
Profit Before Tax	5.28	5.58	22.45	19.70	20.59	9.18
Tax	1.78	2.04	5.17	5.00	5.46	2.69
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.10	-0.11	1.06	0.03	0.00	0.00
Reported Net Profit	3.60	3.65	16.22	14.67	15.13	6.50
Extraordinary Items	0.00	-0.04	0.00	0.00	0.00	0.00
Adjusted Net Profit	3.60	3.69	16.22	14.67	15.13	6.50
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	55.99	52.34	36.61	21.95	6.81	0.32
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.50	0.00	0.00	0.00
P & L Balance carried down	59.59	55.99	52.34	36.61	21.95	6.81
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	5.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.50	0.00	0.00
Earnings Per Share-Unit Curr	0.65	0.67	15.93	14.67	15.13	6.50
Earnings Per Share(Adj)-Unit Curr	0.65	0.13	3.19	2.93	3.03	1.30
Book Value-Unit Curr	23.16	21.61	80.35	57.91	43.25	28.11
Book Value(Adj)-Unit Curr	23.16	4.32	16.07	11.58	8.65	5.62

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)